Federal contract award
75N92021C00034
AWARD A CONTRACT FOR RADX TECH - LUMIRADX SHALL PROVIDE A SARS-COV-2 & FLU A/B HIGH SENSITIVITY AG ASSAY
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | NATIONAL INSTITUTES OF HEALTH NHLBI |
| NAICS | 334516 — Analytical Laboratory Instrument Manufacturing |
| PSC | Q301 — Reference Laboratory Testing |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $5.2M |
| Current contract value | $5.2M |
| Potential contract value / ceiling | $5.2M |
| Start date | Sep 30, 2021 |
| Current end date | May 31, 2022 |
| Potential end date | May 31, 2022 |
| Latest award activity | Oct 25, 2024 |
| Source loaded | Aug 15, 2026 |
Funding and modification history
Showing the latest 1 of 1 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Oct 25, 2024 | P00003 | $0 | EO14042 AWARD A CONTRACT FOR RADX TECH - LUMIRADX SHALL PROVIDE A SARS-COV-2 & FLU A/B HIGH SENSITIVITY AG ASSAY |
Research next steps
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.